- About Us
- Executive Committee
- Company Papers
- Your Privacy
- PCRS Community
- Regional Leads
- Respiratory Leadership Programme
- Affiliated Groups
- Your Questions Answered
- Respiratory Researchers
- Annual Conference
- Affiliated Group Leaders Events
- Inspiring Primary Care Respiratory Research and Researchers
- Respiratory Leadership Programme
- Asthma Right Care (ARC)
- Tobacco Dependency
- Inhaler Devices
- Professional Development
- Primary Care Respiratory Update
- Primary Care Respiratory Academy
- npj | Primary Care Respiratory Medicine
- Resources for Patients and Carers
- Contact Us
Confirmed Conference Exhibitors
We look forward to welcoming our exhibitors to the conference. Exhibitors have had no input into the agenda of the conference, with the exception of the satellite symposium sessions, for which the sponsoring companies are fully responsible
Abbott’s nutrition business partners with healthcare professionals worldwide to offer the most trusted names in nutrition products for every stage of life — from nourishing infants and new mums for a healthier start, to meeting the distinct nutritional needs of people with acute or chronic conditions so people can get back to doing the things they love. For further information, visit www.nutrition.abbott/uk
Action for Pulmonary Fibrosis is a national charity that was set up in 2013 by patients, family members and medical specialists. Our vision is to find a cure for pulmonary fibrosis so that everyone affected by the disease has a better future. We provide support to patients and their families, raise awareness, campaign and educate to improve access to the highest standard of care for everyone affected. We are committed to finding a cure through funding research. Please visit www.actionpulmonaryfibrosis.org for more information.
Established in 2009, and with a product portfolio encompassing generic and branded pharmaceuticals, medical devices and diagnostics, Aspire Pharma is a rapidly growing UK pharmaceutical company that continues to exceed expectations. While providing significant economic savings for the NHS and sustainable value for both customers and partners alike, the company prides itself on delivering innovation that translates in to real world benefits for patients in the UK.
The Association for Respiratory Technology & Physiology (ARTP), through standards of training and quality assurance, are the professional guardians of physiological measurement issues in respiratory medicine in the UK. With over 35 years of experience in the design and delivery of lung function services, ARTP provides the only national, professionally recognised, qualifications in Respiratory Function Testing and Spirometry in the UK. ARTP also recommends standards for the design and delivery of lung function services through position papers from ARTP Working Groups on the structure, function and content of lung function facilities in the UK. An important function of the ARTP is the provision of opportunities for Continuing Professional Development. The ARTP organises meetings and courses on many respiratory topics. To find out more, visit the ARTP website at http://www.artp.org.uk.
The Association of Chartered Physiotherapists in Respiratory Care is a National Body which promotes health and best practice in Respiratory Physiotherapy for the benefit of all. The ACPRC was originally established in 1980, and with over 1,000 members is one of the largest professional networks of physiotherapists in the UK . Each year, the ACPRC publish the only journal dedicated to Respiratory Physiotherapy, a Respiratory Review and a monthly e-Newsletter with all of the latest updates in Respiratory Care. The committee also deliver a wide range of short courses, a bi-annual conference and support members with a wide range of general enquiries. Since 2016, the four core pillars of the ACPRC have been: Connecting People Sharing Knowledge and Skills Research and Best Practice Leadership and Innovation The ACPRC is run by an elected commiittee of members who support the organisation on a voluntary basis. The committee itself is made up of a wide range of specialist physiotherapists, many of whom are leading figures in their area of expertise.
The Association of Respiratory Nurse Specialists (ARNS) was formed in 1997 by respiratory nurses, for respiratory nurses, and this ethos is still very true today. ARNS remains the only nursing-led membership organisation within the UK respiratory specialty field. Today, our organisation benefits from the participation of more than 1,600 members across the UK. Our annual conference, held in May each year, is the highlight of the respiratory nursing calendar. ARNS collaborates with other respiratory care organisations, as well as government and NHS initiatives in order to influence policy and developments for respiratory services, such as the NICE and BTS Guidelines. ARNS is a member of the European Respiratory Nurses Association. Secretariat Office: 10 Hartley Close, Stoke Poges, Bucks, SL3 6NS Email: firstname.lastname@example.org Phone: 07740117902 Website: www.arns.co.uk Twitter: @ARNS_UK Your can also find us on Facebook
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular & Metabolic Diseases and Respiratory. The Company also is selectively active in the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information, please visit www.astrazeneca.com and follow us on Twitter @AstraZeneca.
Atlantic Pharma is a family owned UK business. We are dedicated to bringing high quality cost-effective medicines to the NHS. Our products are manufactured in Switzerland, ensuring the highest quality and made available through UK wholesalers providing a reliable supply. We pride ourselves on finding product solutions that can give real world benefits to patients at an affordable cost to the NHS.
About Boehringer Ingelheim Improving the health and quality of life of patients is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. The company concentrates on developing innovative therapies that can improve patients’ lives. In animal health, Boehringer Ingelheim stands for advanced prevention. Family-owned since it was established in 1885, Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies. Some 50,000 employees create value through innovation daily for the three business areas: human pharmaceuticals, animal health and biopharmaceuticals. As a family-owned company, Boehringer Ingelheim plans in generations and focuses on long-term success. The company therefore aims at organic growth from its own resources with simultaneous openness to partnerships and strategic alliances in research. In everything it does, Boehringer Ingelheim naturally adopts responsibility towards mankind and the environment. More information about Boehringer Ingelheim can be found on www.boehringer-ingelheim.com or in our annual report: http://annualreport.boehringer-ingelheim.com.
One in five of us has problems with our breathing. Millions more are at risk. We’re the only UK charity looking after the nation’s lungs. With your support, we’ll make sure that one day everyone breathes clean air with healthy lungs. For further information, please visit www.blf.org.uk. For help and support, call the BLF Helpline on 03000 030 555. To donate £5 to help the BLF fight lung disease, please text LUNGS to 70500.
Chiesi Limited is the UK affiliate of Chiesi Farmaceutici S.p.A. It is headquartered in Manchester and employs over 250 employees. Chiesi Farmaceutici is an international research-focussed Healthcare Group based in Parma, Italy, with over 80 years of experience in the pharmaceutical industry. The group employs nearly 5,000 people and has affiliates in 26 countries. Chiesi researches, develops and markets innovative drugs in the respiratory therapeutics, specialist medicine and rare disease areas. Its R&D organisation is also headquartered in Parma, Italy, and integrated with six other key R&D groups in France, the USA, the UK, Sweden and Denmark to advance Chiesi's pre-clinical, clinical and registration programmes. .
Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of patients. Since forming over 80 years ago, Cipla has emerged as one of the most respected pharmaceutical names in India and has a presence in more than 80 countries. Whilst delivering a long-term sustainable business, Cipla recognises its duty to provide affordable medicines. Cipla’s emphasis on access for patients was recognised globally for the pioneering role played in HIV/AIDS treatment as the first pharmaceutical company to provide a triple combination anti-retroviral (ARV) in Africa at less than a dollar a day and thereby treating many millions of patients since 2001. Cipla is one of the world’s largest suppliers of pMDIs and is now introducing its range of respiratory brands into the UK.
Circassia is a specialty pharmaceutical company focused on respiratory disease. Our market-leading NIOX® products are used by specialists throughout the UK and around the world to aid asthma diagnosis and management. Allergic airway inflammation is the major underlying cause of asthma. By measuring the FeNO (the fractional exhaled nitric oxide) with NIOX®, clinicians can evaluate allergic airway inflammation in patients with underlying asthma. As a result, NIOX® is used to improve asthma management by assisting in diagnosis, determining responsiveness to inhaled corticosteroids, tailoring inhaled steroid use, monitoring treatment compliance and reducing exacerbations. For more information, please visit www.niox.com or get in touch at email@example.com.
Respiratory specialists Clement Clarke International, originators of the Mini-Wright Standard Peak Flow Meter. Clement Clarke have a series of innovations to showcase, one being the new Clip-Tone E device; an inhaler guidance tool designed to improve inhaler technique, now available on prescription. The improved version of the Able Spacer, which features a two-way valve, operating at less than 10L/min inspiratory flow, which is highly recommended for children and COPD patients; also made from an anti-microbial, low static plastic. Clement Clarke’s portfolio comprises of an extensive range of inhaler technique training tools; these devices work alongside our Apps, offering a fun and engaging solution to inhaler technique training. Please visit our stand for more information and demonstrations.
Improving the lives of people living with long term conditions - Education for Health is a leading UK based educational charity, supporting nurses and healthcare professionals working with patients living with long term conditions. Through our clinically led education and training, research and advocacy work, we are playing an integral role in enabling healthcare professionals to deliver the best possible care for patients. We offer a comprehensive range of education and training, including free-to-access online resources, workshops and accredited Level 5, 6 and 7 modules which can be taken as standalone courses or used to achieve a full DipHE, BSc or MSc degree programme. Our academic team are clinicians and experts in their subject areas who continue to work in practice, bringing a real-life vibrancy to all that we do. Innovative teaching techniques and learning materials enable students to combine work and professional development. Website: www.educationforhealth.org Email: firstname.lastname@example.org Twitter: @EdforHealth Facebook: www.facebook.com/EdforHealth/
GSK is a science-led global healthcare company with a mission to help people do more, feel better and live longer. For more than 50 years, GSK has been a leader in respiratory, helping patients with respiratory disease better manage their condition. Working in collaboration with the scientific community, we remain at the cutting-edge of scientific research into innovative medicines with the aim of helping to treat patients’ symptoms and reduce the risk of their disease. For further information please visit www.gsk.com.
Glenmark brings 40+ Years of Pharmaceuticals Knowledge and Experience and has more than 12,000 employees. Operations cover 80+ Countries across the world. Glenmark are an innovations based company ranked in the top 75 Ranked Pharma & Biotech companies of the world. The pipeline has a strong respiratory focus with multiple devices/brands planned. Glenmark Pharmaceuticals Europe Ltd head office is based in the UK. They have established 10+ years of providing Pharmaceuticals to the NHS primary and Secondary Care.
Healthcare 21 is one of Northern Europe’s largest privately-owned healthcare companies with operations across the UK, Germany, Austria and Ireland. We are a leading provider of sales, marketing, customer service, engineering service and logistics for a variety of market leading global medtech manufacturers. We are delighted to once again be sponsoring this year’s Primary Care Respiratory Society. Our team are proud to be showcasing and launching the World first FeNO measuring device for Asthma patients for home use. The device has won awards for its lightweight, easy-to use, initiative design which gives quick accurate FeNO readings using a traffic light classification. As ideal add-on, the Vivatmo app complements Vivatmo me. Thus, patients can keep a closer look on their asthma. Come and visit us on HC21stand for your free demonstration and special promotion of this device.
The ILD Interdisciplinary Network (ILD-IN) aims to provide a supportive network for health professionals of all disciplines working in interstitial lung diseases. ILD-INs purpose is, to provide support, promote ILD specialty practice through education and professional development and to influence the policy of ILD care.
Intermedical Cardio Respiratory is a leading specialist provider of cardio-respiratory diagnostic devices and therapy products. This year, we will be demonstrating the Bedfont NObreath monitor and performing FeNO testing on the stand. This portable device measures FeNO in a single breath sample and facilitates better management of Asthma in patients. We will also be showcasing our Spirometer range from MIR and ndd.
MA Healthcare is an established provider of nursing and medical education, offering printed resources, conferences and websites for professionals at all levels of the health services Key to the success of MA Healthcare are our journals. From established titles such as British Journal of Nursing, British Journal of Midwifery and British Journal of Hospital Medicine to a growing range of more specialist titles, our journals are renowned for their currency, clarity and accessibility. Quay Books, our book division, also epitomises these values, with a range that includes many key texts in medical and nursing education. Building on our relationships with key opinion leaders in many fields, MA Healthcare organises over 50 medical and nursing conferences a year, covering topics as diverse as oncology and eating disorders.
As the UK's leading medical supplies company, Williams provide a full 'end to end' service which combines the market's best prices with an extensive range of value-added benefits. Supported by Vyaire, Williams is the approved Primary Care supplier of Micro Medical Spirometers and CO Monitors, including the Gold Standard MicroLab and MicroLoop. • Technical support and advice for practitioners completing their ARTP/BTS accreditation • Conforms with ‘A guide to Performing Quality Assured Diagnostic Spirometry’ • GLI (Global Lung Initiative) predicted values, automatic interpretation and reproducibility guidance • FREE software updates • Software exports results directly to SystmOne and EMIS Visit the Micro Medical at Williams Medical stand today to benefit from… • FREE technical support and advice; ideal for practitioners completing their ARTP/BTS accreditation • FREE product demos • Exclusive discounts • Value-added takeaways, including FREE spirometer calibration logbooks
my mhealth provide the only NHS-approved apps for the management of long-term conditions. We are the leading supplier of self-management and rehabilitation apps for patients with their COPD, Asthma, Diabetes and Heart Disease. These patient apps interact with a condition specific clinical interface, enabling efficient, population level remote models of care.
Napp Pharmaceuticals Limited is a UK healthcare company with a strong track record in bringing high-quality, innovative medicines to UK health professionals and their patients. We are a committed long-term NHS provider in respiratory medicine, supporting the delivery of real-world evidence and education. We aim to provide high-quality asthma medicines that meet genuine needs, make a positive difference to patients’ lives and offer value to the NHS
npj Primary Care Respiratory Medicine is published in partnership between Primary Care Respiratory Society and Springer Nature. Authors whose papers are accepted for publication within npj Primary Care Respiratory Medicine are required to pay an article processing charge (APC). All members of PCRS are entitled to a discounted APC (50% reduction on the full rate) if an article for which they are the corresponding author is accepted for publication within the journal. The discounted rate is also available to anyone who has presented an abstract or poster at a PCRS conference within the previous year. Find out more: nature.com/npjpcrm
SpiroConnect is the new and improved turbine spirometer designed by Chris Lawson, Micro Medical’s Technical Director for 27 years and creator of the MicroLab, MicroLoop and SpiroUSB spirometers. With its patented vertical turbine, SpiroConnect is more sensitive to low respiratory flow rates and therefore perfect for testing COPD and Asthma patients. SpiroConnect is also the most comprehensively integrated with the EMIS, SystmOne and Vision GP clinical systems, filing up to 40 user selectable Read codes and a PDF spirometry report in seconds at the end of the test. SpiroConnect is safer, easier, faster and more accurate. Please visit the Numed stand or website, or call us to find out more. www.numed.co.uk 0114 2433896
Nutricia pioneers nutritional solutions that help people live longer, more joyful and healthier lives. Building on more than a century of nutritional research and innovation, Nutricia continues to transform lives through the power of nutrition. Nutricia’s science-based products and services support healthy growth and development during the first 1000 days. Nutricia also helps to address some of the world’s biggest health challenges including conditions in early life such as pre-term birth, faltering growth, food allergy and rare metabolic diseases, as well as age-related conditions and chronic disease, such as frailty, cancer, stroke, COPD and early Alzheimer’s disease. As part of Danone, Nutricia fully embraces the company’s “One Planet. One Health” vision reflecting that the health of people and the health of the planet are interconnected and therefore seeks to protect and nourish both. For more information visit www.nutricia.com
Optimum Patient Care is a not-for-profit social enterprise with over 12 years of working to support primary care in the UK. We provide a quality improvement programme to support GP revaluation requirements, research support services (observational, database, clinical trials), and data services in primary care. Our quality improvement programme for asthma and COPD is provided at no cost to GP surgeries. We also provide respiratory review clinics depending on availability of funding and ongoing projects. GP practices receiving our quality improvement programme contribute anonymised data to the OPC Research Database (OPCRD) for scientific research in chronic diseases to understand and to improve health outcomes. We provide GP practices with paid opportunities to participate in ethically approved clinical trials, including large cluster randomised trials (e.g ARRISA-UK study, MAGNIFY study and IMP2ART study), and support them to undertake trials. We can also deliver bespoke datasets for research to both academic and non-academic collaborators.
Orion Pharma (UK) Ltd. is a subsidiary of Orion Corporation, a pharmaceutical company based in Finland. Orion carries out extensive research with a goal of introducing new treatments into global markets. Core therapy areas in Orion’s product and research strategy are Respiratory, Critical Care, CNS, Women’s Health and oncology.
PARI develop solutions for people suffering from respiratory diseases and have been a leading manufacturer within the respiratory field for well over 100 years. PARI have added a range of diagnostic devices to their portfolio, consisting of the SpiroSense® spirometry solution and the Bosch Vivatmo FeNO testing solution. The SpiroSense solution comprises an easy-to-use PC spirometer for healthcare professionals, with the option of adding a mobile handheld device for patients to use at home. SpiroSense automatically calibrates, removing the need for time-consuming calibration and servicing. The Vivatmo FeNO testing solution offers a simple, maintenance-free option that can be added to the patient pathway. Intuitive user guidance and visual animation enables easy measurements. This year PARI is also celebrating 25 Years in the UK. For further information visit the PARI stand. PARI Medical Ltd The Old Sorting Office Rosemount Avenue West Byfleet Surrey KT14 6LB Tel: 01932 341122 Fax: 01932 341134 www.pari.com email: email@example.com
Pfizer applies science and global resources to bring therapies to people that extend and significantly improve their lives. Pfizer colleagues strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. The Pfizer global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with the organisation’s responsibility as one of the world's premier innovative biopharmaceutical companies, Pfizer collaborates with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. In the UK, Pfizer has its business headquarters in Surrey and is a major supplier of medicines to the NHS. To learn more about Pfizer’s commitments, please visit www.pfizer.co.uk
The Primary Care Respiratory Academy (PCRA) is an educational programme tailored to primary care health professionals and those who commission respiratory services. It consists of Clinical, Commissioning and Community Pharmacy Platforms. Working in partnership with the Primary Care Respiratory Society (PCRS), we provide expert-guided learning and peer-to-peer exchange through live meetings and online resources. Visit our website to learn more: respiratoryacademy.co.uk
The aim of the Pulmonary Fibrosis Trust is to provide personal support to people affected by Pulmonary Fibrosis, a very debilitating and life-limiting illness. We offer practical, emotional and financial support where there is a need. We also raise awareness of the illness and in particular the challenges people face on a daily basis.
Respiratory Futures is the platform to visit for resources to support integrated respiratory care, commissioning, innovation and networking. It works to join the dots between the many points, people and places that make up the diverse UK respiratory sector. This is with the aim of fostering the sharing of best practice, the reduction of duplication and the development of new models of care which best meet the needs of patients and help to reduce healthcare inequalities. Respiratory Futures works in partnership with the British Thoracic Society and NHS England to support the NHSE Long Term Plan’s ambitions for respiratory services. In addition to an active website, Respiratory Futures holds live debates to promote discussion and learning in the respiratory community. The website includes: - The integrated futures map which holds information on each STP, Health Board and Health and Social Care Trust across the UK. - The features section which includes interviews, articles and case studies covering innovative models of care, pressing topics and new projects in the respiratory field. - Respiratory resources including relevant publications, a jargon buster and a directory of respiratory organisations. - Information about and recordings of debates held and coming soon.
Sanofi Pasteur is the vaccines division of Sanofi. Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We help prevent illness with vaccines and provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions. With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe. Sanofi, Empowering Life SAGB.MIS.19.07.1262 July 2019
Siemens Healthineers enables healthcare providers worldwide to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalising healthcare. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services. www.siemens-healthineers.co.uk
We have recently launched the Smart Peak Flow meter for use in asthma (www.smartpeakflow.com). The Smart Peak Flow meter is a small electronic device that plugs into any smart phone and allows for the easy recording, storing and sharing of peak flow results.
TriOn Pharma is a rapidly growing UK pharmaceutical company having two operations; licence pharma product and wholesaling. TriOn product portfolio contain Pharmaceutical, Nutraceuticals and Medical Devices offering significant cost saving for NHS. TriOn Respiratory specialist’s product consist of PulmoClear- Hypertonic NaCl for inhalation solution 3%,6% & 7% and Inhaler spacer device as EasyChamber Spacer in all variance are now available on prescription in the UK with great saving for NHS/clinicians. Please visit our stand for more information and product sample; firstname.lastname@example.org
Trudell Medical UK Limited (TM-UK) TM-UK is committed to enhancing the quality of life for people of all ages with respiratory conditions. We are part of Trudell Medical International, a family owned healthcare company that designs, develops and manufactures a wide range of high quality, innovative medical devices and is home to a global Aerosol Lab and Research Centre. AeroChamber Plus* Flow-Vu* Anti-Static Valved Holding Chamber (VHC) and our award-winning Aerobika* OPEP device, are now available on prescription in the UK. Company Contact Details Email email@example.com Telephone 01256 338 400 Website www.trudellmed.com/trudell-medical-uk
For over 50 years Vitalograph have been committed to providing high quality respiratory products and services. Vitalograph spirometers are the natural choice for quick and easy high quality lung function testing with low running costs. We understand data accuracy is vital, our products can integrate effortlessly and our easy to use products and software provide you with accurate results, in a timely manner, every time. Our highly knowledgeable teams are always available to provide technical support when needed. Visit our stand for a demonstration of our pocket monitors and screeners, and extensive range of leading PC-based, handheld and desktop spirometers. Ask us about connectivity to your practice software (EMIS, SystmOne and Vision) which can save you significant time and effort. We also offer great value consumables which provide protection for patients, medical personnel and equipment whilst also reducing device cleaning requirements.